Liberty Capital Management, Inc. Abbott Laboratories Transaction History

Liberty Capital Management, Inc.

$404 Million
Q1 2024

A detailed history of Liberty Capital Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Liberty Capital Management, Inc. holds 40,705 shares of ABT stock, worth $4.16 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares

40,705

Previous 41,002 0.72%

Holding current value

$4.16 Million

Previous $4.51 Million 2.5%

% of portfolio

1.15%

Previous 1.19%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	SELL	$109.52 - $120.96 $32,527 - $35,925	-297 Reduced 0.72%	40,705 $4.63 Million
Q4 2023 Jan 24, 2024	SELL	$90.19 - $110.4 $38,691 - $47,361	-429 Reduced 1.04%	41,002 $4.51 Million
Q3 2023 Oct 18, 2023	BUY	$95.53 - $114.62 $410,970 - $493,095	4,302 Added 11.59%	41,431 $4.01 Million
Q2 2023 Jul 25, 2023	BUY	$100.78 - $112.29 $52,607 - $58,615	522 Added 1.43%	37,129 $4.05 Million
Q1 2023 Apr 11, 2023	SELL	$96.86 - $114.01 $17,628 - $20,749	-182 Reduced 0.49%	36,607 $3.71 Million

Q4 2022 Jan 23, 2023	BUY	$95.06 - $111.52 $23,479 - $27,545	247 Added 0.68%	36,789 $0
Q3 2022 Nov 09, 2022	BUY	$96.76 - $112.03 $1.92 Million - $2.22 Million	19,852 Added 118.95%	36,542 $3.54 Million
Q3 2022 Nov 08, 2022	SELL	$96.76 - $112.03 $1.96 Million - $2.27 Million	-20,222 Reduced 54.78%	16,690 $1.62 Million
Q2 2022 Jul 25, 2022	BUY	$102.07 - $123.37 $13,269 - $16,038	130 Added 0.35%	36,912 $4.01 Million
Q1 2022 May 04, 2022	BUY	$114.02 - $139.04 $15,050 - $18,353	132 Added 0.36%	36,782 $4.35 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $180,804 - $221,384	-1,565 Reduced 4.1%	36,650 $5.16 Million
Q3 2021 Oct 22, 2021	BUY	$116.66 - $129.06 $1,283 - $1,419	11 Added 0.03%	38,215 $4.51 Million
Q2 2021 Jul 16, 2021	BUY	$105.79 - $124.53 $44,749 - $52,676	423 Added 1.12%	38,204 $4.43 Million
Q1 2021 Apr 19, 2021	BUY	$108.84 - $128.23 $22,203 - $26,158	204 Added 0.54%	37,781 $4.53 Million
Q4 2020 Jan 20, 2021	BUY	$105.0 - $114.42 $76,545 - $83,412	729 Added 1.98%	37,577 $4.11 Million
Q2 2020 Jul 22, 2020	BUY	$76.57 - $98.0 $47,013 - $60,172	614 Added 1.69%	36,848 $3.37 Million
Q1 2020 Apr 13, 2020	BUY	$62.82 - $91.86 $18,720 - $27,374	298 Added 0.83%	36,234 $2.86 Million
Q3 2019 Oct 15, 2019	SELL	$81.84 - $88.74 $64,735 - $70,193	-791 Reduced 2.15%	35,936 $3.01 Million
Q2 2019 Jul 15, 2019	BUY	$72.88 - $85.0 $13,701 - $15,980	188 Added 0.51%	36,727 $3.09 Million
Q1 2019 Apr 22, 2019	BUY	$66.22 - $80.06 $28,805 - $34,826	435 Added 1.2%	36,539 $2.92 Million
Q4 2018 Jan 24, 2019	SELL	$65.56 - $74.27 $29,960 - $33,941	-457 Reduced 1.25%	36,104 $2.61 Million
Q3 2018 Oct 26, 2018	BUY	$60.81 - $73.36 $690,254 - $832,709	11,351 Added 45.03%	36,561 $2.68 Million
Q2 2018 Jul 17, 2018	BUY	$57.57 - $63.54 $257,222 - $283,896	4,468 Added 21.54%	25,210 $1.54 Million
Q1 2018 Apr 25, 2018	BUY	$56.27 - $63.62 $131,334 - $148,489	2,334 Added 12.68%	20,742 $1.24 Million
Q4 2017 Jan 16, 2018	SELL	$53.68 - $57.47 $2,469 - $2,643	-46 Reduced 0.25%	18,408 $1.08 Million
Q3 2017 Oct 25, 2017	BUY	$48.06 - $53.64 $886,899 - $989,872	18,454	18,454 $1.04 Million

Others Institutions Holding ABT

# of Institutions

3,131

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $179B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Liberty Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Liberty Capital Management, Inc. with notifications on news.

Account

Liberty Capital Management, Inc. Abbott Laboratories Transaction History